Top News

PURE Bioscience Gets $2.376M In PIPE

San Diego-based PURE Bioscience, a publicly held developer of antimicrobial compounds, said today that it has raised $2.376M in a private placement. Name of the investors were not disclosed. The firm said it sold 1,080,000 new shares of its stock at $2.20 per share. The firm said the new funding will go towards working capital.





Latest Headlines

Browse Issues


Keep up with all of the latest Southern California high tech news via email (it's free!)

or Cancel